All Stories

  1. Causal Association Between Sarcopenia‐Related Traits and COVID ‐19 Outcomes: A Bidirectional Two‐Sample Mendelian Randomization Study
  2. The unequal malaria burden attributable to child growth failure: a global analysis among children under five from 1990 to 2021
  3. Mucosal Immunity and Autoimmune Diseases: New Perspectives From Mechanisms to Treatment
  4. Appendicular Skeletal Muscle Mass Prediction Equation for Older Adults: Anthropometric, Physical, and Biochemical Indicators
  5. Exposure‐Response Associations Between Air Pollution and Laboratory‐Confirmed Influenza Cases in Anhui Province, China: A Two‐Stage Modeling Study
  6. Phylogenetic Patterns and Spatiotemporal Evolution of H1N1pdm09 in Anhui Province, China, 2009–2023
  7. Applications and Challenges of Digital Health in Rheumatology
  8. Inequality in Burden of Tracheal, Bronchial, and Lung Cancer Attributable to Residential Radon Exposure: Global Analysis and Country‐Level Patterns in High Granite/Marble Consuming Countries
  9. Associations of chronic disease status and the risk of new-onset hip or femoral fractures in older population
  10. Epidemiological and experimental evidence of environmental factor-related autoimmune thyroid disease: A systematic review
  11. Global, regional, and national burden of environmental heat and cold exposure in adults aged 55 years and older from 1990 to 2021: a trend analysis
  12. Burden and Predictions of Untreated Caries in China, 1990–2039: A Systematic Analysis for the Global Burden of Disease Study 2019
  13. Evolutionary patterns and future perspectives of joint replacement in arthritis patients: a comprehensive analysis of findings over the past decades
  14. The impact of population ageing on musculoskeletal disorders in 204 countries and territories, 1990-2021: global burden and healthcare costs
  15. Temporal Trend and Health Inequality in the Burden of Autoimmune Diseases Among Older Adolescents and Young Adults Aged 15-29 Years
  16. Investigation of Genetic Causality Between Epstein–Barr Virus Infection and Risk of Autoimmune Diseases
  17. Leveraging Bibliometric Methods to Uncover the Research Landscape Within the Field of Rheumatology
  18. Rheumatic Diseases and Sinusitis: Epidemiological Features, Immune Mechanisms, and Treatment Challenges
  19. Global landscape of neonatal disorders attributed to environmental and maternal risks over three decades
  20. Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4
  21. Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period
  22. Unveiling new insights into migraine risk stratification using machine learning models of adjustable risk factors
  23. Global, regional, and national perspectives on aortic aneurysm burden from 1992 to 2021: temporal patterns and age-period-cohort analyses
  24. Genetic Insights Into the Relationship Between Menstrual Factors and Site‐/Age‐Specific Bone Mineral Density
  25. Association Between Mixed Exposure to Dioxins and Dioxin-Like Polychlorinated Biphenyls and Obesity Among US Adults
  26. Global Burden of Diseases Dataset, Methodology and Its Use in Rheumatic and Musculoskeletal Diseases
  27. Associations of accelerated biological aging and metabolic heterogeneity of obesity with rheumatoid arthritis: a prospective cohort study
  28. Genetic causality between modifiable risk factors and the risk of rheumatoid arthritis: Evidence from Mendelian randomization
  29. Global burden of musculoskeletal disorders in children and adolescents from 1990 to 2021: a joint point regression and decomposition analysis
  30. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: A population-based study
  31. Infodemiology as a Powerful Tool in Public Health: Bridging the Digital Divide for Better Well-being
  32. Differences in the expression of long noncoding RNAs in peripheral blood mononuclear cells indicate potential biomarkers for rheumatoid arthritis
  33. Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia
  34. Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases
  35. Association of gene polymorphisms and the decreased expression of long non-coding RNA LOC553103 with rheumatoid arthritis
  36. Transmission Dynamics and Spatiotemporal Evolution of H1N1pdm09 in Anhui Province, China, 2009--2023
  37. Genetic Links Between Metabolic Syndrome and Osteoarthritis: Insights From Cross-Trait Analysis
  38. Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic
  39. Changes in frailty and depressive symptoms among middle-aged and older Chinese people: a nationwide cohort study
  40. Associations between air pollutants and acute exacerbation of drug-resistant tuberculosis: evidence from a prospective cohort study
  41. Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants
  42. Serum albumin mediates the associations between heavy metals and two novel systemic inflammation indexes among U.S. adults
  43. Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019
  44. Causal Relationships between Air Pollutant Exposure and Bone Mineral Density and the Risk of Bone Fractures: Evidence from a Two-Stage Mendelian Randomization Analysis
  45. Global, regional and national burden of CKD in children and adolescents from 1990 to 2019
  46. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019
  47. Salt reduction behavior of adults in Anhui province in 2019: a cross-sectional survey of 3,378 participants
  48. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040
  49. Impact of short-term exposure to ambient air pollution on osteoarthritis: a multi-city time-series analysis in Central-Eastern China
  50. Changes in frailty and depressive symptoms among middle-aged and elderly Chinese: a nationwide cohort study
  51. Homocysteine as a trigger and potential therapeutic target for autoimmune diseases
  52. The effect of air pollution exposure on the risk of outpatient visits for periodontitis: a time-series study
  53. Climate change and daily outpatient visits for dermatomyositis in Hefei, China: a time-series study
  54. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation
  55. Emerging roles of air pollution and meteorological factors in autoimmune eye diseases
  56. Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019
  57. Global Chronic obstructive pulmonary disease burden attributable to air pollution from 1990 to 2019
  58. Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization
  59. Effectiveness of the recurrent laryngeal nerve monitoring during endoscopic thyroid surgery: systematic review and meta-analysis
  60. No genetically predicted association between sarcopenia and COVID-19
  61. Association between short-term exposure to ambient air pollution and outpatient visits for pulpitis in Hefei, China: a time series study
  62. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019
  63. Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period
  64. Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases
  65. The effect of air pollution exposure on risk of outpatient visits for Sjogren's syndrome: A time-series study
  66. Associations between particulate matter air pollutants and hospitalization risk for systemic lupus erythematosus: a time-series study from Xi’an, China
  67. Arthritis and incident pulmonary diseases in middle-aged and elderly Chinese: a longitudinal population-based study
  68. Shared genetic architecture between type 2 diabetes and COVID-19 severity
  69. Novel insight into the aetiology of rheumatoid arthritis gained by a cross-tissue transcriptome-wide association study
  70. Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective
  71. Investigation on Probable Association Between IL-13, IL-13RA1, and IL-13RA2 Genes Polymorphism and Pulmonary Tuberculosis
  72. Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic
  73. Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
  74. Association Between Genetic Polymorphisms of lncRNA NEAT1 and Pulmonary Tuberculosis Risk, Clinical Manifestations in a Chinese Population
  75. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus
  76. Social Support and Depression Among Pulmonary Tuberculosis Patients in Anhui, China
  77. New‐onset autoimmune phenomena post‐COVID‐19 vaccination
  78. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on 18F‐FDG PET/CT for Patients with Colorectal Cancer
  79. Association between non-optimal temperature and hospitalizations for gout in Anqing, China: a time-series analysis
  80. Emerging role of air pollution in chronic kidney disease
  81. Association between ambient air pollution and tuberculosis risk: A systematic review and meta-analysis
  82. TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population
  83. Lower-than-standard particulate matter air pollution reduced life expectancy in Hong Kong: A time-series analysis of 8.5 million years of life lost
  84. Non-causal Effect of Circulating Vitamin D Levels on the Risk of Rheumatoid Arthritis: A Two-sample Mendelian Randomization Study
  85. Emerging role of air pollution and meteorological parameters in COVID‐19
  86. Single Immunoglobulin IL‐1‐Related Receptor (SIGIRR) Gene rs7396562 Polymorphism and Expression Level in Rheumatoid Arthritis
  87. Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
  88. Association of Leptin Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Population
  89. Associations of extreme temperatures with hospitalizations and post-discharge deaths for stroke: What is the role of pre-existing hyperlipidemia?
  90. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study
  91. Identification of new susceptibility loci associated with rheumatoid arthritis
  92. Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study
  93. Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population
  94. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy
  95. Association of Melatonin Pathway Gene’s Single-Nucleotide Polymorphisms with Systemic Lupus Erythematosus in a Chinese Population
  96. Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study
  97. Therapeutic potential of aryl hydrocarbon receptor in autoimmunity
  98. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis
  99. Seasonality and global public interest in psoriasis: an infodemiology study
  100. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus
  101. Plasma galectin‐3 levels do not differ in systemic lupus erythematosus patients
  102. Correction: Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis
  103. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus
  104. Semaphorin-3A, semaphorin-7A gene single nucleotide polymorphisms, and systemic lupus erythematosus susceptibility
  105. Association between Interleukin 35 Gene Single Nucleotide Polymorphisms and Systemic Lupus Erythematosus in a Chinese Han Population
  106. Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis
  107. Differentially expressed circular RNAs in systemic lupus erythematosus and their clinical significance
  108. Emerging role of lncRNAs in systemic lupus erythematosus
  109. Circulating Levels of Osteoprotegerin, Osteocalcin and Osteopontin in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  110. Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
  111. The expression levels of long noncoding RNAs lnc0640 and lnc5150 and its gene single-nucleotide polymorphisms in rheumatoid arthritis patients
  112. RNAi Silencing of HIF-1α Ameliorates Lupus Development in MRL/lpr Mice
  113. Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  114. Association of single nucleotide polymorphisms in resistin gene with rheumatoid arthritis in a Chinese population
  115. Postpartum depressive mood (PDM) among Chinese women: a meta-analysis
  116. NLRP3: A promising therapeutic target for autoimmune diseases
  117. Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients
  118. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis
  119. Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus
  120. Meta-analysis of GWAS on both Chinese and European populations identifies GPR173 as a novel X chromosome susceptibility gene for SLE
  121. Emerging role of semaphorin-3A in autoimmune diseases
  122. Identification ofST3AGL4,MFHAS1, CSNK2A2andCD226as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning
  123. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients
  124. Association ofinterleukin-10gene single nucleotide polymorphisms with rheumatoid arthritis in a Chinese population
  125. Association of interleukin-10 gene single nucleotide polymorphisms with susceptibility to systemic lupus erythematosus in a Chinese population
  126. Potential link between m 6 A modification and systemic lupus erythematosus
  127. Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis
  128. Coagulation cascade and complement system in systemic lupus erythematosus
  129. Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs
  130. Elevated seroprevalence of Toxoplasma gondii in AIDS/HIV patients: A meta-analysis
  131. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis
  132. Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus
  133. Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus
  134. Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis
  135. Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus
  136. Association between serum/plasma adiponectin levels and immune-mediated diseases: a meta-analysis
  137. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis
  138. Altered microRNAs expression in T cells of patients with SLE involved in the lack of vitamin D
  139. Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis
  140. Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases
  141. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis
  142. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
  143. Effect of Short Message Service on Management of Pulmonary Tuberculosis Patients in Anhui Province, China: A Prospective, Randomized, Controlled Study
  144. Association of HLA-DQB1 polymorphisms with rheumatoid arthritis: a meta-analysis
  145. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus
  146. Association of leptin and leptin receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population
  147. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus
  148. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis
  149. Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
  150. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
  151. The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
  152. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus
  153. Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis
  154. Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population
  155. Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus risk: an updated meta-analysis
  156. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis
  157. Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases
  158. Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus Erythematosus
  159. A meta-analysis of the relationship between MYO9B gene polymorphisms and susceptibility to Crohn’s disease and ulcerative colitis
  160. Plasma levels of adipokines in systemic lupus erythematosus patients
  161. Evidence of epistatic interaction betweenDPP4andCCR6in patients with rheumatoid arthritis
  162. Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis
  163. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis
  164. Circular RNAs and systemic lupus erythematosus
  165. Plasma melatonin levels do not differ in SLE patients
  166. MicroRNA-210 and its theranostic potential
  167. Emerging role of adipokines in systemic lupus erythematosus
  168. Relationship between the IL12B (rs3212227) gene polymorphism and susceptibility to multiple autoimmune diseases: A meta-analysis
  169. TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis
  170. Association between rs6887695 and 3′-untranslated region polymorphisms within theinterleukin-12Bgene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis
  171. Genetic Polymorphism (rs329498) in the Pellino-1 Gene as Possible Predisposal Factor for Systemic Lupus Erythematosus in a Chinese Population
  172. Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment
  173. Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population
  174. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
  175. Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus
  176. Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis
  177. Therapeutic potential of IL-15 in rheumatoid arthritis
  178. Gene-Based Meta-Analysis of Genome-Wide Association Study Data Identifies Independent Single-Nucleotide Polymorphisms inANXA6as Being Associated With Systemic Lupus Erythematosus in Asian Populations
  179. Association Study of Matrix Metalloproteinases Gene Polymorphisms with Susceptibility to Rheumatoid Arthritis: A Meta-Analysis
  180. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
  181. Emerging role of long noncoding RNAs in autoimmune diseases
  182. Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus
  183. Association of UBASH3A gene polymorphisms and systemic lupus erythematosus in a Chinese population
  184. Increased carotid intima–media thickness (CIMT) levels in patients with type 1 diabetes mellitus (T1DM): A meta-analysis
  185. Epidemiological characteristics and influential factors of hand, foot and mouth disease (HFMD) reinfection in children in Anhui province
  186. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis
  187. Associations Between PADI4 Gene Polymorphisms and Rheumatoid Arthritis: An Updated Meta-analysis
  188. Association of lymphotoxin alpha polymorphism with systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis
  189. Decreased UBASH3A mRNA Expression Levels in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
  190. A literature review on the patients with autoimmune diseases following vaccination against infections
  191. Genome-wide search followed by replication reveals genetic interaction ofCD80andALOX5APassociated with systemic lupus erythematosus in Asian populations
  192. Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus
  193. IL-17A-producing CD8+T cells as therapeutic targets in autoimmunity
  194. Association between CARD8 rs2043211 Polymorphism and Inflammatory Bowel Disease: A Meta-Analysis
  195. microRNAs function in CD8+ T cell biology
  196. Long noncoding RNAs: Novel insights into gastric cancer
  197. Novel insights into Tim-4 function in autoimmune diseases
  198. The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity
  199. Tc17 Cells in Immunity and Systemic Autoimmunity
  200. Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus
  201. Association of IL-21 polymorphisms (rs907715, rs2221903) with susceptibility to multiple autoimmune diseases: A meta-analysis
  202. Association of FCGR2A-R/H131 polymorphism with susceptibility to systemic lupus erythematosus among Asian population: a meta-analysis of 20 studies
  203. Decreased Flow-Mediated Dilatation in Patients with Systemic Lupus Erythematosus: a Meta-analysis
  204. The Risk Factors of Avascular Necrosis in Patients with Systemic Lupus Erythematosus: a Meta-analysis
  205. Therapeutic potential of STAT4 in autoimmunity
  206. Emerging Role of SIGIRR rs7396562(T/G) Polymorphism in Systemic Lupus Erythematosus in a Chinese Population
  207. Therapeutic Potential of HO-1 in Autoimmune Diseases
  208. Association study ofinterleukin-19 rs2243188polymorphism with systemic lupus erythematosus in a Chinese population
  209. CTLA-4 CT60(rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis
  210. SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications
  211. Therapeutic potential of tyrosine kinase 2 in autoimmunity
  212. Relationship between the IL-4 gene promoter -590C/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis
  213. Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: A meta-analysis
  214. Associations between TNF gene polymorphisms (−308 A/G, −238 A/G, −1031 C/T and −857 T/C) and genetic susceptibility to T1D: a meta-analysis
  215. Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis
  216. Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus
  217. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis
  218. Serum levels of cytokines in systemic lupus erythematosus
  219. New evidence for roles of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus
  220. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases
  221. Association of XPC Gene Polymorphisms with Susceptibility to Prostate Cancer: Evidence from 3,936 Subjects
  222. Genetic interaction between genes involved in NF-κB signaling pathway in systemic lupus erythematosus
  223. Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk
  224. Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province
  225. Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus
  226. Lack of association between the polymorphisms of hypoxia-inducible factor 1A (HIF1A) gene and SLE susceptibility in a Chinese population
  227. Expression of Ets-1 and FOXP3 mRNA in CD4+CD25+ T regulatory cells from patients with systemic lupus erythematosus
  228. Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: A prospective cohort study
  229. Associations of Interleukin-4 Receptor Gene Polymorphisms (Q551R, I50V) with Rheumatoid Arthritis: Evidence from a Meta-Analysis
  230. Lack of association of IL-6 polymorphism with rheumatoid arthritis/type 1 diabetes: A meta-analysis
  231. Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians
  232. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis
  233. Identification of MFG-E8 as a novel therapeutic target for diseases
  234. Perspectives of the relationship between IL-7 and autoimmune diseases
  235. Impact of Environmental Factors on Efficacy of Glucocorticoids in Chinese Population with Systemic Lupus Erythematosus
  236. IL-10RB rs2834167 (A/G) Polymorphism Is Associated with the Susceptibility to Systemic Lupus Erythematosus: Evidence from a Study in Chinese Han Population
  237. Lack of association between IL-23R gene polymorphisms and systemic lupus erythematosus in a Chinese population
  238. A bibliometric study of literature on SLE research in PubMed (2002–2011)
  239. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: A meta-analysis
  240. Decreased ITGAM and FcγRIIIA mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
  241. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
  242. Association between leptin and systemic lupus erythematosus
  243. IL-32 with potential insights into rheumatoid arthritis
  244. Association of the −1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis
  245. Therapeutic potential of SIGIRR in systemic lupus erythematosus
  246. D18S880 Microsatellite Polymorphism of Carnosinase Gene and Diabetic Nephropathy: A Meta-Analysis
  247. Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients
  248. Sex-specific differences in the relationship between the single-nucleotide polymorphism rs2298804 ofFCER1Aand the susceptibility to systemic lupus erythematosus in a Chinese Han population
  249. MicroRNA-21 with therapeutic potential in autoimmune diseases
  250. Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: A meta-analysis
  251. Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population
  252. Emerging role of interleukin-22 in autoimmune diseases
  253. CTLA-4 -1722T/C Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Meta-analysis Involving Ten Separate Studies
  254. Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians
  255. Interferon regulatory factor 5 and autoimmune lupus
  256. Association of interleukin-18 and systemic lupus erythematosus
  257. Gene–Gene and Gene-Sex Epistatic Interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in Systemic Lupus Erythematosus
  258. IL-33
  259. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: A meta-analysis
  260. Association of the interleukin-10 gene polymorphism (–1082A/G) with systemic lupus erythematosus: a meta-analysis
  261. MicroRNA-101, mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in systemic lupus erythematosus
  262. Association Study of IFIH1 rs1990760 Polymorphism with Systemic Lupus Erythematosus in a Chinese Population
  263. Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis
  264. Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus
  265. Targeting IRF4 in autoimmune diseases
  266. Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population
  267. Association of TNFSF4 polymorphisms with systemic lupus erythematosus: a meta-analysis
  268. Association of Interleukin 1α Promoter Polymorphism (–889C/T) with Susceptibility to Systemic Sclerosis
  269. Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis
  270. A Single Nucleotide Polymorphism of IL-21 Gene is Associated with Systemic Lupus Erythematosus in a Chinese Population
  271. Association of c-Jun Gene Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Chinese Population
  272. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
  273. Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysis
  274. Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis
  275. IRF7, a functional factor associates with systemic lupus erythematosus
  276. APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al
  277. Association of MicroRNA-146a with Autoimmune Diseases
  278. The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus
  279. New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: Comment on the article by Ichikawa et al
  280. New evidence for a role ofMICAin the pathogenesis of systemic lupus erythematosus: Comment on the article by Yoshida et al
  281. Association of PTPN22 C1858T Polymorphism and Type 1 Diabetes: A Meta-analysis
  282. Role of CREM in systemic lupus erythematosus
  283. The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE
  284. Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis
  285. New evidence for roles of antinucleosome antibodies in systemic lupus erythematosus
  286. A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis
  287. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China
  288. Interleukin-18: Friend or Foe for Systemic Sclerosis?
  289. Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population
  290. Association of CD247 with systemic lupus erythematosus in Asian populations
  291. Targeting IL-6 promoter polymorphism −174G/C should be dependent on ethnicity
  292. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus
  293. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience
  294. Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors
  295. Lack of association of interleukin-18 gene promoter −607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis
  296. Role of microRNA-155 in autoimmunity
  297. The dual nature of Ets-1: Focus to the pathogenesis of systemic lupus erythematosus
  298. The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis
  299. Is transforming growth factor β always necessary for generation of pathogenic Th17 cells in autoimmune disease? Comment on the article by Morita et al
  300. Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis
  301. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients
  302. Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis
  303. Association of interleukin-6 promoter polymorphism (−174 G/C) with systemic lupus erythematosus
  304. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention
  305. Polymorphisms of the TIM-1 and TIM-3 genes are not associated with systemic lupus erythematosus in a Chinese population
  306. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
  307. Association of ITGAM polymorphism with systemic lupus erythematosus: a meta-analysis
  308. Osteopontin receptor-dependent regulation of Th1 and Th17 responses in autoimmune diseases: Comment on the article by Chen et al
  309. Increased serum RANTES in patients with systemic lupus erythematosus
  310. Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus
  311. Saikosaponins: a potential treatment option for systemic lupus erythematosus
  312. Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus
  313. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases
  314. ELF1 is associated with systemic lupus erythematosus in Asian populations
  315. Epidemiological investigation of scarlet fever in Hefei City, China, from 2004 to 2008
  316. Prevalence and clinical significance of 15 autoantibodies in patients with new-onset systemic lupus erythematosus
  317. Elevated serum levels of MMP-2, MMP-3, and MMP-13 in Chinese patients with systemic lupus erythematosus
  318. Cholecystokinin octapeptide (CCK-8): friend or foe for rheumatoid arthritis?
  319. The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet's disease
  320. Tumor necrosis factor-α-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations
  321. 1,25-Dihydroxyvitamin D3 may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: Comment on the article by Colin et al
  322. Anti-Ro antibody and clinical manifestations: lessons from systemic lupus erythematosus in the elderly
  323. Family Factors Associated With Suicide Attempts Among Chinese Adolescent Students: A National Cross-Sectional Survey
  324. BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus
  325. Comment on “Human Pregnancy Up-regulates Tim-3 in Innate Immune Cells for Systemic Immunity”
  326. IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
  327. Serum IL-17 level in systemic lupus erythematosus patients
  328. TWEAK as a target for therapy in systemic lupus erythematosus
  329. Therapeutic potential of IL-27 in systemic lupus erythematosus
  330. Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison
  331. Lack of association of FcγRIIIb polymorphisms with systemic lupus erythematosus: a meta-analysis
  332. A meta-analysis of the association of STAT4 polymorphism with systemic lupus erythematosus
  333. Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus
  334. Role of the Fcγ receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis
  335. Protective role of moderate alcohol drinking in systemic lupus erythematosus
  336. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus
  337. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls
  338. Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis
  339. TIM-3 as a new therapeutic target in systemic lupus erythematosus
  340. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases
  341. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma
  342. Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population
  343. Tuberculosis in systemic lupus erythematosus in Chinese patients
  344. Paclitaxel: Friend or Foe for Systemic Lupus Erythematosus?
  345. Season of birth: A potential influential factor for quality of life
  346. Increased serum interleukin 17 in patients with systemic lupus erythematosus
  347. Anti-α-actinin antibodies in relation to new-onset systemic lupus erythematosus and lupus nephritis
  348. Decreased serum IL-22 levels in patients with systemic lupus erythematosus
  349. High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus
  350. FAS −1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls
  351. Clinical and serological correlates of anti-Sm autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases
  352. Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese
  353. Susceptibility to systemic lupus erythematosus may be related to gene dosage effect of the X chromosome
  354. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis
  355. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus
  356. Metabolic syndrome: A potential culprit for Alzheimer’s disease?
  357. Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis
  358. Radix Astragali: A promising new treatment option for systemic lupus erythematosus
  359. Meta analysis on the association between FcγRIIa-R/H131 polymorphisms and systemic lupus erythematosus
  360. Anti-neutrophil Cytoplasmic Antibodies in New-onset Systemic Lupus Erythematosus and Lupus Nephritis
  361. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus
  362. Reactivation of inactive X chromosome: A potential culprit and therapeutic target for Systemic lupus erythematosus
  363. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients